CAPTRUST Financial Advisors
WHWK

CAPTRUST Financial Advisors’s Whitehawk Therapeutics WHWK Stock Holding History

CAPTRUST Financial Advisors’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-404
Closed -$5K – 4175
2022
Q2 		$5K Buy
404
+389
+2,593% +$5.78K ﹤0.01% 4129
2022
Q1 		$0 Hold
15
– – ﹤0.01% 5171
2021
Q4 		$0 Hold
15
– – ﹤0.01% 4947
2021
Q3 		$0 Buy
+15
New +$457 ﹤0.01% 4788

Other funds holding WHWK

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

CAPTRUST Financial Advisors's WHWK Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Whitehawk Therapeutics (WHWK) in Q3 2022, closing a stake of 404 shares — an estimated $5K sold.

CAPTRUST Financial Advisors first reported a position in WHWK in Q3 2021 and held it in 4 quarters. The position peaked at $5K in Q2 2022. 68 funds tracked by Wall St. Rank hold WHWK as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Whitehawk Therapeutics position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 404 Whitehawk Therapeutics shares in Q3 2022, an estimated $5K.
  • CAPTRUST Financial Advisors first reported a position in Whitehawk Therapeutics in Q3 2021 and held it in 4 quarters.
  • CAPTRUST Financial Advisors's Whitehawk Therapeutics position peaked at $5K in Q2 2022.
  • 68 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.